This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations by Shu-Pei Wu in Kidney Disease Treatment
Introduction
Shu-Pei Wu is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of kidney diseases. His innovative work focuses on methods to inhibit APOL1, a key factor in certain kidney conditions.
Latest Patents
Shu-Pei Wu holds a patent titled "Methods of treating APOL-1 dependent focal segmental glomerulosclerosis." This application describes methods of inhibiting APOL1 and treating APOL1-mediated kidney diseases. It involves administering Compound I and/or a pharmaceutically acceptable salt thereof. The patent also outlines pharmaceutical compositions that include Compound I and/or a pharmaceutically acceptable salt thereof.
Career Highlights
Wu is currently associated with Vertex Pharmaceuticals, Inc., a leading biotechnology company. His work at Vertex focuses on developing innovative therapies for serious diseases, showcasing his commitment to advancing medical science.
Collaborations
Shu-Pei Wu collaborates with talented professionals, including Navita Mallalieu and Ifeatu Egbuna. These partnerships enhance the research and development efforts in the field of kidney disease treatment.
Conclusion
Shu-Pei Wu's contributions to the treatment of kidney diseases through his innovative patent demonstrate his expertise and dedication to improving patient outcomes. His work continues to inspire advancements in medical research and therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile